{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:02:11Z","timestamp":1780538531304,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-024-11086-2","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T10:58:48Z","timestamp":1738061928000},"page":"5835-5853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate"],"prefix":"10.1007","volume":"29","author":[{"given":"Elora","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"1","key":"11086_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ygeno.2020.09.059","volume":"113","author":"A Rahimi","year":"2021","unstructured":"Rahimi A, Mirzazadeh A, Tavakolpour SJG (2021) Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics 113(1):1221\u20131232","journal-title":"Genomics"},{"key":"11086_CR2","unstructured":"Craven J (2022) COVID-19 therapeutics tracker. Regulatory Affairs Professionals Society (RAPS)"},{"issue":"7857","key":"11086_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","volume":"593","author":"S Cele","year":"2021","unstructured":"Cele S, Gazy I, Jackson L, Hwa S-H, Tegally H, Lustig G et al (2021) Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma. Nature 593(7857):142\u2013146","journal-title":"Nature"},{"issue":"10","key":"11086_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4155\/tde.13.87","volume":"4","author":"JD Unciti-Broceta","year":"2013","unstructured":"Unciti-Broceta JD, Del Castillo T, Soriano M, Magez S, Garcia-Salcedo JA (2013) Novel therapy based on camelid nanobodies. Ther Deliv 4(10):1321\u20131336","journal-title":"Ther Deliv"},{"issue":"1","key":"11086_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S (2013) Nanobodies: natural single-domain antibodies. Annu Rev Biochem 82(1):775\u2013797","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"11086_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F, Coppo P, Kn\u00f6bl P, Hovinga JAK et al (2019) Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med 380(4):335\u2013346. https:\/\/doi.org\/10.1056\/NEJMoa1806311","journal-title":"N Engl J Med"},{"issue":"4","key":"11086_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","volume":"14","author":"I Astuti","year":"2020","unstructured":"Astuti I (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr: Clin Res Rev 14(4):407\u2013412","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"issue":"2","key":"11086_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280","journal-title":"Cell"},{"key":"11086_CR9","unstructured":"Duffy AM, Bouchier-Hayes DJ, Harmey JH (2013) Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF. In: Madame Curie Bioscience Database [Internet]: Landes Bioscience"},{"key":"11086_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3881","volume":"14","author":"Z Vadasz","year":"2012","unstructured":"Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E (2012) Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Res Ther 14:1\u20138","journal-title":"Arthritis Res Ther"},{"issue":"6518","key":"11086_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856\u2013860","journal-title":"Science"},{"issue":"14","key":"11086_CR12","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1016\/j.bpj.2021.05.026","volume":"120","author":"Z-L Li","year":"2021","unstructured":"Li Z-L, Buck M (2021) Neuropilin-1 assists SARS-CoV-2 infection by stimulating the separation of Spike protein S1 and S2. Biophys J 120(14):2828\u20132837","journal-title":"Biophys J"},{"key":"11086_CR13","unstructured":"FDA Approved Antibody-Drug Conjugates (ADCs) Up To 2022 (2019\/10\/30 17:21:08) Biopharma PEG. https:\/\/www.biochempeg.com\/article\/74.html"},{"issue":"20","key":"11086_CR14","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/molecules25204764","volume":"25","author":"U Hafeez","year":"2020","unstructured":"Hafeez U, Parakh S, Gan HK, Scott AM (2020) Antibody\u2013drug conjugates for cancer therapy. Molecules 25(20):4764","journal-title":"Molecules"},{"key":"11086_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1208\/s12248-014-9710-8","volume":"17","author":"JR McCombs","year":"2015","unstructured":"McCombs JR, Owen SCJTAJ (2015) Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry. AAPS J 17:339\u2013351","journal-title":"AAPS J"},{"key":"11086_CR16","doi-asserted-by":"publisher","first-page":"153303382110101","DOI":"10.1177\/15330338211010117","volume":"20","author":"W Kang","year":"2021","unstructured":"Kang W, Ding C, Zheng D, Ma X, Yi L, Tong X et al (2021) Nanobody conjugates for targeted cancer therapy and imaging. Technol Cancer Res Treat 20:15330338211010116","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"11086_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, Robertson DL (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19(7):409\u2013424","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"11086_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00284-022-02807-7","volume":"79","author":"N Eslami","year":"2022","unstructured":"Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, Baghi HB (2022) SARS-CoV-2: receptor and co-receptor tropism probability. Curr Microbiol 79(5):133","journal-title":"Curr Microbiol"},{"issue":"2","key":"11086_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C et al (2017) The ClusPro web server for protein\u2013protein docking. Nat Protocols 12(2):255\u2013278","journal-title":"Nat Protocols"},{"issue":"W1","key":"11086_CR20","first-page":"W490","volume":"47","author":"MB Carvalho","year":"2019","unstructured":"Carvalho MB, Molina F, Felicori LF (2019) Yvis: antibody high-density alignment visualization and analysis platform with an integrated database. Nucl Acids Res 47(W1):W490\u2013W495","journal-title":"Nucl Acids Res"},{"issue":"suppl_2","key":"11086_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/nar\/gkl190","volume":"34","author":"V Parthiban","year":"2006","unstructured":"Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucl Acids Res 34(suppl_2):239\u2013242","journal-title":"Nucl Acids Res"},{"issue":"W1","key":"11086_CR22","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan Y, Zhang D, Zhou P, Li B, Huang SY (2017) HDOCK: a web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy. Nucl Acids Res 45(W1):W365\u2013W373","journal-title":"Nucl Acids Res"},{"key":"11086_CR23","doi-asserted-by":"publisher","unstructured":"Lindahl ER (2008) Molecular dynamics simulations. Methods Mol Biol 443:3\u201323. https:\/\/doi.org\/10.1007\/978-1-59745-177-2_1","DOI":"10.1007\/978-1-59745-177-2_1"},{"issue":"4","key":"11086_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang YJN (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725\u2013738","journal-title":"Nat Protoc"},{"issue":"suppl_2","key":"11086_CR25","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucl Acids Res 35(suppl_2):W407\u2013W410","journal-title":"Nucl Acids Res"},{"key":"11086_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I (2014) AllerTOP v. 2\u2014a server for in silico prediction of allergens. J Mol Model 20:1\u20136","journal-title":"J Mol Model"},{"issue":"9","key":"11086_CR27","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 8(9):e73957","journal-title":"PLoS ONE"},{"issue":"13","key":"11086_CR28","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucl Acids Res 31(13):3784\u20133788","journal-title":"Nucl Acids Res"},{"issue":"1","key":"11086_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jov\u010devska","year":"2020","unstructured":"Jov\u010devska I, Muyldermans SJB (2020) The therapeutic potential of nanobodies. BioDrugs 34(1):11\u201326","journal-title":"BioDrugs"},{"issue":"W1","key":"11086_CR30","doi-asserted-by":"publisher","first-page":"W406","DOI":"10.1093\/nar\/gkw336","volume":"44","author":"D Bhattacharya","year":"2016","unstructured":"Bhattacharya D, Nowotny J, Cao R, Cheng J (2016) 3Drefine: an interactive web server for efficient protein structure refinement. Nucl Acids Res 44(W1):W406\u2013W409","journal-title":"Nucl Acids Res"},{"issue":"1","key":"11086_CR31","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1038\/s41467-021-24963-3","volume":"12","author":"D Sun","year":"2021","unstructured":"Sun D, Sang Z, Kim YJ, Xiang Y, Cohen T, Belford AK, Huet A, Conway JF, Sun J, Taylor DJ (2021) Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes. Nat Commun 12(1):4676","journal-title":"Nat Commun"},{"key":"11086_CR32","unstructured":"Origin(Pro) (2022) OriginLab corporation. Northampton, MA, USA"},{"issue":"1","key":"11086_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/prot.24167","volume":"81","author":"D Bhattacharya","year":"2013","unstructured":"Bhattacharya D, Cheng J (2013) 3Drefine: Consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization. Proteins: Struct, Funct, Bioinformat 81(1):119\u2013131","journal-title":"Proteins: Struct, Funct, Bioinformat"},{"issue":"4","key":"11086_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3201\/eid2704.210016","volume":"27","author":"S Amit","year":"2021","unstructured":"Amit S, Beni SA, Biber A, Grinberg A, Leshem E, Regev-Yochay G (2021) Postvaccination COVID-19 among healthcare workers, Israel. Emerging Infect Dis 27(4):1220\u20131222. https:\/\/doi.org\/10.3201\/eid2704.210016","journal-title":"Emerging Infect Dis"},{"key":"11086_CR35","unstructured":"Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC (2021) COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci 25(3)"},{"issue":"1","key":"11086_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13337-021-00751-x","volume":"33","author":"H Charoute","year":"2022","unstructured":"Charoute H, Elkarhat Z, Elkhattabi L, El Fahime E, Oukkache N, Rouba H, Barakat AJV (2022) Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target. Virusdisease 33(1):23\u201331","journal-title":"Virusdisease"},{"issue":"7909","key":"11086_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","volume":"605","author":"T Shapira","year":"2022","unstructured":"Shapira T, Monreal IA, Dion SP, Buchholz DW, Imbiakha B, Olmstead AD et al (2022) A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 605(7909):340\u2013348","journal-title":"Nature"},{"issue":"2","key":"11086_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10867-020-09548-3","volume":"46","author":"H Aysima","year":"2020","unstructured":"Aysima H, Burak E (2020) ModiBodies: A computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity. J Biol Phys 46(2):189\u2013208","journal-title":"J Biol Phys"},{"issue":"11","key":"11086_CR39","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1080\/07391102.2020.1773316","volume":"39","author":"V Sharma","year":"2021","unstructured":"Sharma V, Chouhan P, Pandey RK, Ojha R, Aathmanathan VS, Krishnan M et al (2021) Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response. J Biomol Struct Dyn 39(11):4051\u20134065","journal-title":"J Biomol Struct Dyn"},{"issue":"26","key":"11086_CR40","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.1073\/pnas.0801221105","volume":"105","author":"R Barderas","year":"2008","unstructured":"Barderas R, Desmet J, Timmerman P, Meloen R, Casal JI (2008) Affinity maturation of antibodies assisted by in silico modeling. Proc Natl Acad Sci 105(26):9029\u20139034","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"11086_CR41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/prot.24230","volume":"81","author":"VZ Spassov","year":"2013","unstructured":"Spassov VZ, Yan L (2013) pH-selective mutagenesis of protein\u2013protein interfaces: in silico design of therapeutic antibodies with prolonged half-life. Proteins: Struct, Funct, Bioinformat 81(4):704\u2013714","journal-title":"Proteins: Struct, Funct, Bioinformat"},{"issue":"1","key":"11086_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41467-021-27610-z","volume":"13","author":"L Hanke","year":"2022","unstructured":"Hanke L, Das H, Sheward DJ, Perez Vidakovics L, Urgard E, Moliner-Morro A et al (2022) A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo. Nat Commun 13(1):155","journal-title":"Nat Commun"},{"issue":"5","key":"11086_CR43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","volume":"181","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, De Vlieger D, Corbett KS, Torres GM, Wang N, Van Breedam W, Roose K, van Schie L, Hoffmann M, P\u00f6hlmann S, Graham BS (2020) Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181(5):1004\u20131015","journal-title":"Cell"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11086-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:01:56Z","timestamp":1764824516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11086"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11086-2","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}